Cargando…
Low cross reactivity between wild type and deamidated AAV can lead to false negative results in immune monitoring T-cell assays
During gene therapy trials, immune responses against adeno-associated virus (AAV) vectors are monitored by antibody assays that detect the humoral and T-cell mediated cellular responses to AAV vectors. T cell assays commonly utilize the collection of patients’ peripheral blood mononuclear cells (PBM...
Autores principales: | Bing, So Jin, Warrington, Stephanee, Mazor, Ronit |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10352612/ https://www.ncbi.nlm.nih.gov/pubmed/37469509 http://dx.doi.org/10.3389/fimmu.2023.1211529 |
Ejemplares similares
-
Differential T cell immune responses to deamidated adeno-associated virus vector
por: Bing, So Jin, et al.
Publicado: (2022) -
Cross-reactivity of SARS-CoV-2 with HIV chemiluminescent assay leading to false-positive results
por: Tan, Shaun S, et al.
Publicado: (2021) -
Oracle or false prophet? Can we predict AAV efficacy based on preexisting antibody titers?
por: Anguela, Xavier M., et al.
Publicado: (2019) -
A false-positive troponin assay leading to the misdiagnosis of myopericarditis
por: Laguë, Marianne, et al.
Publicado: (2022) -
POCT errors can lead to false potassium results
por: Buño, Antonio, et al.
Publicado: (2021)